Mark Connor


  • 4692 Citations
  • 39 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile


I am Pharmacologist interested in analgesics and other psychoactive drugs, particularly cannabinoids and opioids. My lab studies how opioids, cannabinoids and related molecules interact with G protein coupled receptors and ion channels to exert their effects. Currently my work is focussed on how clinically used opioids interact with naturally occuring variants of human opioid receptors, the pharmacology and toxicity of emerging synthetic cannabinoid receptors agonists (Spice/K2) and the molecular mechanisms underlying the potential therapeutic actions of cannabis and its components.

Education/Academic qualification

Pharmacology, PhD, University of Washington

Pharmacology, Genetics, BSc (Hons), University of Sydney

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
mu Opioid Receptor Medicine & Life Sciences
Opioid Analgesics Medicine & Life Sciences
Pharmacology Medicine & Life Sciences
Cannabinoids Medicine & Life Sciences
Neurons Medicine & Life Sciences
Periaqueductal Gray Medicine & Life Sciences
Ligands Medicine & Life Sciences
Calcium Channels Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2019

Research Outputs 1991 2019

Dark classics in Chemical Neuroscience: Δ 9 -tetrahydrocannabinol

Banister, S. D., Arnold, J. C., Connor, M., Glass, M. & Mcgregor, I. S., 15 May 2019, In : ACS Chemical Neuroscience. 10, 5, p. 2160-2175 16 p.

Research output: Contribution to journalReview articleResearchpeer-review

Medical Marijuana

New-generation azaindole-adamantyl-derived synthetic cannabinoids

Longworth, M., Reekie, T. A., Blakey, K., Boyd, R., Connor, M. & Kassiou, M., 28 Feb 2019, In : Forensic Toxicology. 37, 2, p. 350-365 16 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Mass spectrometry
Mass Spectrometry

Regulation of heterologously expressed 5-HT1B receptors coupling to potassium channels in AtT-20 cells

Heblinski, M., Bladen, C. & Connor, M., 1 Feb 2019, In : British Journal of Pharmacology. 176, 3, p. 451-465 15 p.

Research output: Contribution to journalArticleResearchpeer-review

Receptor, Serotonin, 5-HT1B
Potassium Channels
G Protein-Coupled Inwardly-Rectifying Potassium Channels

Synthesis and in vitro evaluation of fluorine-18 benzimidazole sulfones as CB2 PET-radioligands

Kallinen, A., Boyd, R., Lane, S., Bhalla, R., Mardon, K., Stimson, D. H. R., Werry, E. L., Fulton, R., Connor, M. & Kassiou, M., 28 May 2019, In : Organic and Biomolecular Chemistry. 17, 20, p. 5086-5098 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Cannabinoid Receptor CB2

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA

Banister, S. D., Adams, A., Kevin, R. C., Macdonald, C., Glass, M., Boyd, R., Connor, M., McGregor, I. S., Havel, C. M., Bright, S. J., Vilamala, M. V., Lladanosa, C. G., Barratt, M. J. & Gerona, R. R., Feb 2019, In : Drug Testing and Analysis. 11, 2, p. 279-291 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Artificial Receptors
Cannabinoid Receptor Agonists
nuclear magnetic resonance
liquid chromatography